• 1
    Weber S., Krüger-Krasagakes S., Grabbe J., Zuberbier T., Czarnetzki B M.. Mast cells. Int J Dermatol 1995: 34: 110.
  • 2
    Czarnetzki B M., Grabbe J., Kolde G., Krüger-Krasagakes S., Welker P., Zuberbier T. Mast cells in the cytokine network: the what, where from and what for. Exp Dermatol 1995: 4: 221226.
  • 3
    Lippert U., Artuc M., Grützkau A. et al. Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells. J Immunol, in press.
  • 4
    Nilsson G., Forsbergnilsson K., Yiang Z., Hallbook F., Nilsson K., Metcalfe DD. Human mast cells express functional TrkA and are a source of nerve growth factor. Eur J Immunol 1997: 27: 22952301.
  • 5
    Christensen L., Simonsen A C W., Heegaard C W., Moestrup S K., Andersen J A., Andreasen P A.. Immunohistochemical localization of urokinase type plasminogen activator, type 1 plasminogen activator inhibitor, urokinase receptor and alpha (2) macroglobulin receptor in human breast carcinomas. Int J Cancer 1996: 66: 441452.
  • 6
    Sillaber C., Baghestanian M., Hofbauser R. et al. Molecular and functional characterization of the urokinase receptor on human mast cells. J Biol Chem 1997: 272: 78247832.
  • 7
    Möller A., Henz B M., Grützkau A. et al. Comparative cytokine gene expression, regulation and release by human mast cells. Immunology 1998: 93: 289295.
  • 8
    Rumsaeng V., Cruikshank W W., Foster B. et al. Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16. J Immunol 1997: 159: 29042910.
  • 9
    Grabbe J., Welker P., Grützkau A. et al. Induction of human leukemic mast cell differentiation by fibroblast supernatants, but not by stem cell factor. Scand J Immunol 1998: 47: 324331.
  • 10
    Nilsson G., Butterfield J H., Nilsson K., Siegbahn A. Stem cell factor is a chemotactic factor for human mast cells. J Immunol 1994: 153: 37173723.
  • 11
    Hartmann K., Henz B M., Krüger-Krasagakes S. et al. C3a and C5a stimulate chemotaxis of human mast cells. Blood 1997: 89: 28632870.
  • 12
    Persinger M A., LePage P., Simard J P.. Mast cell numbers in incisional wounds in rat skin as a function of distance, time and treatment. Br J Dermatol 1983: 108: 179187.
  • 13
    Atkins F M., Clark R A F. Mast cells and fibrosis. Arch Dermatol 1987: 123: 191193.
  • 14
    Seibold J R., Giorno R C., Claman H N.. Dermal mast cell degranulation in systemic sclerosis. Arthritis Rheum 1990: 33: 17021709.
  • 15
    Levi-Schaffer F., Rubinchik E. Activated mast cells are fibrogenic for 3T3 fibroblasts. J Invest Dermatol 1995: 104: 9991003.
  • 16
    Claman H N.. Mast cells and fibrosis. The relevance to scleroderma. Rheum Dis Clin N Am 1990: 16: 141151.
  • 17
    Hebda P A., Collins M A., Tharp M D.. Mast cell and myofibroblast in wound healing. Dermatol Clin 1993: 11: 685696.
  • 18
    Wichmann B E.. The mast cell count during the process of wound healing: an experimental investigation on rats. Acta Pathol Microbiol Scand 1955: 108: 135.
  • 19
    Haas N., Hamann K., Grabbe J., Cremer B., Czarnetzki B M.. Expression of the high affinity IgE receptor on human Langerhans cells. Acta Derm Venereol (Stockh) 1992: 72: 271272.
  • 20
    Maurer D., Fiebiger E., Reininger B. et al. Expression of functional high affinity immunoglobulin E receptors (Fc-RI) on monocytes of atopic individuals. J Exp Med 1994: 179: 745750.
  • 21
    Greenberg G., Burnstock G. A novel cell-to-cell interaction between mast cells and other cell types. Exp Cell Res 1983: 147: 113.
  • 22
    Galli S J.. New insights into “The riddle of the mast cells”: microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 1990: 62: 533.
  • 23
    Harvima I T., Horsmanheimo L., Naukkarinen A., Horsmanheimo M. Mast cell proteinases and cytokines in skin inflammation. Arch Dermatol Res 1994: 287: 6167.
  • 24
    Irani A M A., Schwartz L B.. Mast cell heterogeneity. Clin Exp Allergy 1989: 19: 143155.
  • 25
    Algermissen B., Bauer F., Schadendorf D., Kropp J D., Czarnetzki B M.. Analysis of mast cell subpopulations (MCT, MCTC) in cutaneous inflammation using novel enzymehistochemical staining techniques. Exp Dermatol 1994: 3: 290297.
  • 26
    Harvima I T., Naukkarinen A., Harvima R J., Aalto M L., Neittaanmäki H., Horsmanheimo M. Quantitative enzyme-histochemical analysis of tryptase- and chymasecontaining mast cells in psoriatic skin. Arch Dermatol Res 1990: 282: 428433.
  • 27
    Irani A A., Schechter N M., Craig S S., DeBlois G., Schwartz L B.. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 1986: 83: 44644468.
  • 28
    Nadel J A.. Biology of mast cell tryptase and chymase. Ann N Y Acad Sci 1991: 629: 319331.
  • 29
    Irani A M A., Gruber B L., Kaufman L D., Kahaleh M B., Schwartz L B.. Mast cell changes in scleroderma. Arthritis Rheum 1992: 35: 933939.
  • 30
    Hermes B., Feldmann-Böddeker I., Krüger-Krasagakes S., Henz B M.. Mast cells express NGF- and GM-CSF-receptors. Comparison of normal versus scar tissue. Arch Derm Res 1997: 289: A40.
  • 31
    Furie B., Furie B C.. The molecular basis of blood coagulation. Cell 1988: 53: 505518.
  • 32
    Werb Z., Banda M J., Jones P A.. Degradation of connective tissue matrices by macrophages. I. Proteolysis of elastin, glycoproteins and collagen by proteinases isolated from macrophages. J Exp Med 1980: 152: 13401357.
  • 33
    Kähäri V M., Saarialho-Kere U. Matrix metalloproteinases in the skin. Exp Dermatol 1997: 6: 199213.
  • 34
    Chapman H A., Stone Jr O L.. Cooperation between plasmin and elastase in elastin degradation by intact murine macrophages. Biochem J 1984: 222: 721728.
  • 35
    Colman R W.. Activation of plasminogen by human plasma kallikrein. Biochem Biophys Res Commun 1969: 35: 273279.
  • 36
    Bouma B N., Griffin J H.. Deficiency of factor XII-dependent plasminogen proactivator in prekallikrein-deficient plasma. J Lab Clin Med 1978: 91: 148155.
  • 37
    Nielsen L S., Kellerman G M., Behrendt N., Picone R., Dano K., Blasi F. A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator: Identification in human tumor cell lines and partial purification. J Biol Chem 1988: 263: 23582363.
  • 38
    Cubellis M V., Nolli M L., Cassani G., Blasi F. Binding of a single chain pro-urokinase to the urokinase receptor of human U937 cells. J Biol Chem 1986: 261: 1581915822.
  • 39
    Stacks M S., Johnson D A.. Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase). J Biol Chem 1994: 269: 94169419.
  • 40
    Harvima I T., Harvima R J., Pentilla I M., Eloranta T O., Horsmanheimo M., Fraki J E.. Effect of human mast cell tryptase on human plasma proenzymes. Int Arch Allergy Appl Immunol 1989: 90: 104108.
  • 41
    Schwartz L B., Bradford T R., Littman B H., Wintroub B U.. The fibrinogenolytic activity of purified tryptase from human lung mast cells. J Immunol 1985: 135: 27622767.
  • 42
    Loskutoff D J., Edgington T S.. Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. Proc Natl Acad Sci USA 1977: 74: 39033907.
  • 43
    Kawano T., Morimoto K., Uemura Y. Partial purification and properties of urokinase inhibitor from human placenta. J Biochem 1970: 67: 333342.
  • 44
    Schaefer B M., Maier K., Eickhoh U., Bechtel M., Kramer M D.. Alpha(2) antiplasmin and plasminogen activator inhibitors in healing human skin wounds. Arch Dermatol Res 1996: 288: 122128.
  • 45
    Bajer J B., Low D A., Simmer R L., Cunningham D D.. Protease-nexin: A cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell 1980: 21: 3745.
  • 46
    Stimler N P., Bach M K., Bloor C M., Hugli T E.. Release of leukotrienes from guinea pig lung stimulated by C5a des arg anaphylatoxin. J Immunol 1982: 128: 22472257.
  • 47
    Sueki H., Whitaker D., Buchsbaum M., Murphy G F.. Novel interactions between dermal dendrocytes and mast cells in human skin. Implications for hemostasis and matrix repair. Lab Invest 1993: 69: 160172.
  • 48
    Ciano P S., Colvin R B., Dvorak A M., McDonagh J., Dvorak H F.. Macrophage migration in fibrin gel matrices. Lab Invest 1986: 54: 6270.
  • 49
    Knox P., Crooks S., Rimmer C S.. Role of fibronectin in the migration of fibroblasts into plasma clots. J Cell Biol 1986: 102: 23182323.
  • 50
    Bolton L L., Montagna W. Mast cells in human ulcers. Am J Dermatopathol 1993: 15: 133138.
  • 51
    Clark R A F. Wound repair: Overview and general considerations. In: ClarkR A F., ed. The molecular and cellular biology of wound repair (2nd edition). New York : Plenum Press, 1996: 335.
  • 52
    Mignatti P., Rifkin D B., Welgus H G., Parks W C.. Proteinases and tissue remodeling. In: ClarkR A F., ed. The molecular and cellular biology of wound repair (2nd edition). New York : Plenum Press, 1996: 427461.
  • 53
    Grondahl-Hansen J., Lund L R., Ralfkiaer E., Ottevanger V., Dano K. Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo. J Invest Dermatol 1988: 90: 790795.
  • 54
    Bechtel M J., Reinartz J., Rox J M., Inndorf S., Schaefer B M., Kramer M D.. Upregulation of cell surface associated plasminogen activation in cultured keratinocytes by interleukin 1 beta and tumor necrosis factor alpha. Exp Cell Res 1996: 223: 395404.
  • 55
    McNeill H., Jensen P J.. A high affinity receptor for urokinase plasminogen activator on human keratinocytes: Characterization and potential modulation during migration. Cell Regul 1990: 1: 843852.
  • 56
    Estreicher A., Mühlhauser J., Carpentier J L., Orci L., Vassalli J D.. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme-inhibitor complexes. J Cell Biol 1990: 111: 783792.
  • 57
    Pollack R., Rifkin D B.. Actin-containing cables within anchorage-dependent rat embryo cells are dissociated by plasmin and trypsin. Cell 1975: 495506.
  • 58
    Fibbi G., Ziche M., Morbidelli L., Magnelli L., Del Rosso M. Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. Exp Cell Res 1988: 179: 385395 [published erratum in Exp Cell Res 186: 1996.
  • 59
    Odekon L E., Sato Y., Rifkin D B.. Urokinase-type plasminogen activator mediates basic fibroblasts growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. J Cell Physiol 1992: 150: 258263.
  • 60
    Pepper M S., Montesano R. Proteolytic balance and capillary morphogenesis. Cell Differ Dev 1990: 32: 319328.
  • 61
    Alessandri G., Rajn K., Gullino P M.. Mobilization of capillary endothelium in vitro induced by effectors of angiogenesis in vivo. Cancer Res 1983: 43: 17901797.
  • 62
    Bowesox J C., Sorgente N. Chemotaxis of aortic endothelial cells in response to fibronectin. Cancer Res 1982: 42: 25472551.
  • 63
    Saksela O., Moscatelli D., Rifkin D B.. The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol 1987: 105: 957963.
  • 64
    Pepper M S., Sappino A P., Montesano R., Orci L., Vassalli J D.. Plasminogen activator inhibitor-1 is induced in migrating endothelial cells. J Cell Physiol 1992: 153: 129139.
  • 65
    Pepper M S., Sappino A P., Stocklin R., Montesano R., Orci L., Vassalli J D.. Up-regulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol 1993: 122: 673684.
  • 66
    Tsuboi R., Sato Y., Rifkin D B.. Correlation of cell migration, cell invasion, receptor number, proteinase production and basic fibroblast growth factor levels in endothelial cells. J Cell Biol 1990: 110: 511517.67.
  • 67
    Montesano R., Pepper M S., Mohle-Steinlen U., Risau W., Wagner E F., Orci L. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell 1990: 62: 435445.
  • 68
    Qu Z., Liebler J M., Powers M R. et al. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 1995: 147: 564573.
  • 69
    Nilsson G., Svensson V., Nilsson K. Constitutive and inducible cytokine mRNA expression in the human mast cell line HMC-1. Scand J Immunol 1995: 42: 7681.
  • 70
    Matrisian L M.. The matrix-degrading metalloproteinases. Bioessays 1992: 14: 455463.
  • 71
    Hatamochi A., Ueki H., Mauch C., Krieg T. Effect of histamine on collagen and collagen mRNA production in human skin fibroblasts. J Dermatol Sci 1991: 2: 407410.
  • 72
    Isseroff R R., Fusenig F E., Rifkin D B.. Plasminogen activator in differentiating mouse keratinocytes. J Invest Dermatol 1983: 80: 217222.
  • 73
    Algermissen B. Die Mastzellproteasen Tryptase und Chymase: Vorkommen und potentielle modulatorische Wirkungen in entzündlichen Dermatosen. Inaugural Dissertation. Free University, Berlin , 1994.
  • 74
    Deuel T F., Kawahara R S., Musteo T A., Pierce A F.. Growth factors and wound healing: Platelet-derived growth factor as a model cytokine. Annu Rev Med 1991: 42: 567584.
  • 75
    Sunderkötter C., Steinbrink K., Goebeler M., Bhardwaj R., Sorg C. Macrophages and angiogenesis. Annu Rev Med 1994: 55: 410422.
  • 76
    Eady R A., Cowen T., Marshall T F., Plummer V., Greaves M W.. Mast cell population density, blood vessel density and histamine content in normal human skin. Br J Dermatol 1979: 100: 623633.
  • 77
    Watanabe Y., Lee S W., Detmar M., Ajioka I., Dvorak H F.. Vascular permeability factor vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells. Oncogene 1997: 14: 20252032.
  • 78
    Yamaguchi H., Ishii E., Saito S. et al. Umbilical vein endoMast cells in cutaneous wound healing thelial cells are an important source of c-kit and stem cell factor which regulate the proliferation of haemopoietic progenitor cells. Br J Haematol 1996: 94: 606611.
  • 79
    Grabbe J., Welker P., Rosenbach T. et al. Release of stem cell factor (SCF) from human keratinocytes (HaCaT) is increased in differentiating versus proliferating cells. J Invest Dermatol 1996: 107: 219224.
  • 80
    Meininger C J., Brightman S E., Kelly K A., Zetter B R.. Increased stem cell factor release by hemangioma-derived endothelial cells. Lab Invest 1995: 72: 4852.
  • 81
    Nilsson G., Butterfield J H., Nilsson K., Siegbahn A. s. Stem cell factor is a chemotactic factor for human mast cells. J Immunol 1994: 153: 37173723.
  • 82
    Schubert C., Christophers E. Mast cells and macrophages in early relapsing psoriasis. Arch Dermatol Res 1985: 277: 352358.
  • 83
    Atkinson J B., Harlan C W., Harlan G C., Virmani R. The association of mast cells and atherosclerosis: a morphologic study of early atherosclerotic lesions in young people. Hum Pathol 1994: 25: 154159.
  • 84
    Mican J M., Metcalfe D D.. Arthritis and mast cell activation. J Allergy Clin Immunol 1990: 86: 677683.
  • 85
    Dimitriadou V., Koutsilieris M. Mast cell tumor cell interactions: for or against tumour growth and metastasis. Anticancer Res 1997: 17: 15411549.
  • 86
    Starkey J R., Crowle P K., Taubenberger S. Mast-cell-deficient W/W mice exhibit a decreased rate of tumor angiogenesis. Int J Cancer 1988: 42: 4852.
  • 87
    Dethlefsen S M., Matsuura N., Zetter B R.. Mast cell accumulation at sites of murine tumor implantation: implications for angiogenesis and tumor metastasis. Invasion Metastasis 199495: 14: 395408.
  • 88
    Kischer C W., Bunce H., Shetlah M R.. Mast cell analyses in hypertrophic scars treated with pressure and mature scars. J Invest Dermatol 1978: 70: 355357.
  • 89
    Matsuda H., Kitamura Y. Migration of stromal cells supporting mast-cell differentiation into open wound produced in the skin of mice. Exp Hematol 1981: 9: 3843.
  • 90
    Trabbucchi E., Radaelli E., Marazzi M. et al. The role of mast cells in wound healing. Int J Tissue React 1988: 10: 367372.
  • 91
    Mucha K H., Huffman J E.. Inflammatory cell stimulation and wound healing in Sphaeridiotrema globulus experimentally infected mallard ducks (Anas platyrhynchos). J Wildl Dis 1991: 27: 428434.
  • 92
    Hebda P A., Collins M A., Tharp M D.. Mast cell and myofibroblast in wound healing. Dermatol Clin 1993: 11: 685696.
  • 93
    Liebler J M., Picou M A., Qu Z., Powers M R., Rosenbaum J T.. Altered immunohistochemical localization of basic fibroblast growth factor after bleomycin-induced lung injury. Growth Factors 1997: 14: 2538.
  • 94
    Murata M., Hara K., Saku T. Dynamic distribution of basic fibroblast growth factor during epulus formation: an immunohistochemical study in an enhanced healing process of the gingiva. J Oral Pathol Med 1997: 26: 224232.
  • 95
    Möller A., Lippert U., Lessmann D. et al. Human mast cells produce IL-8. J Immunol 1993: 151: 32613266.
  • 96
    Gordon J R., Galli S J.. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 1990: 346: 274276.
  • 97
    Grützkau A., Krüger-Krasagakes S., Baumeister H. et al. Synthesis, storage and release of Vascular Endothelial Growth Factor (VEGF/VPF) by Human Mast cells: Implications for the biological significance of VEGF206. Mol Biol Cell 1998: 875884.
  • 98
    Dvorak A M., Kissell S. Granule changes of human skin mast cells characteristic of piecemeal degranulation and associated with recovery during wound healing in situ. J Leukoc Biol 1991: 49: 197210.
  • 99
    Nanney L B., Mueller S G., Bueno R., Peiper S C., Richmond A. Distributions of melanoma growth stimulatory activity of growth-regulated gene and the interleukin-8 receptor B in human wound repair. Am J Pathol 1995: 147: 12481260.
  • 100
    Fahey T J., Sherry B., Tracey K J. et al. Cytokine production in a model of wound healing: the appearance of MIP-1, MIP-2, cachectin/TNF and IL-1. Cytokine 1990: 2: 9299.
  • 101
    Montrucchio G., Lupia E., Battaglia E. et al. Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J Exp Med 1994: 180: 377382.
  • 102
    Petzelbauer P., Watson C A., Pfau S E., Pober J S.. IL-8 and angiogenesis: evidence that human endothelial cells lack receptors and do not respond to IL-8 in vitro. Cytokine 1995: 7: 267272.
  • 103
    Yoshida S., Ono M., Shono T. et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alphadependent angiogenesis. Mol Cell Biol 1997: 17: 40154023.
  • 104
    Fajardo L F., Kwan H H., Kowalski J., Prionas S D., Allison A C.. Dual role of tumor necrosis factor-alpha in angiogenesis. Am J Pathol 1992: 140: 539544.
  • 105
    Gruber B L., Schwartz L B., Ramamurthy N S., Irani A M., Marchese M J.. Activation of latent rheumatoid synovial collagenase by human mast cell tryptase. J Immunol 1988: 140: 39363942.
  • 106
    Taipale J., Lohi J., Saarinen J., Kovanen P T., Keski-Oja J. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem 1995: 270: 46894696.
  • 107
    Gruber B L., Marchese M J., Suzuki et al. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J Clin Invest 1989: 84: 16571662.
  • 108
    Lees M., Taylor D J., Wooley D E.. Mast cell proteinases activate precursors forms of collagenase and stromelysin, but not of gelatinase A and B. Eur J Biochem 1994: 223: 171177.
  • 109
    Saarinen J., Kalkkinen N., Welgus H G., Kovanen P T.. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond mast cell chymase. J Biol Chem 1994: 269: 1813418140.
  • 110
    Blair R J., Meng H., Marchese M J. et al. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest 1997: 99: 26912700.
  • 111
    Kessler D A., Langer R S., Pless N A., Folkman J. Mast cells and tumor angiogenesis. Int J Cancer 1976: 18: 703709.
  • 112
    Marks R M., Roche W R., Czerniecki M., Penny R., Nelson D S.. Mast cell granules cause proliferation of human icrovascular endothelial cells. Lab Invest 1986: 55: 289294.
  • 113
    Yayon A., Klagsbrun M., Esko J D., Leder P., Ornitz D M.. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991: 64: 841848.
  • 114
    Gitay-Goren H., Soker S., Vlodavsky W., Neufeld G. The binding of vascular endothelial growth factor to its receptor is dependent on cell surface-associated heparin-like molecules. J Biol Chem 1992: 267: 60936098.
  • 115
    Sakai K., Ren S L., Schwartz L B.. A novel heparin dependent processing pathway for human tryptase: autocatalysis followed by activation with dipeptidyl peptidase 1. J Clin Invest 1996: 97: 988995.
  • 116
    Reed J A., Albino A P., McNutt N S.. Human cutaneous mast cells express basic fibroblast growth factor. Lab Invest 1995: 72: 215222.
  • 117
    Yayon A., Klagsbrun M., Esko J D., Leder P., Ornitz D M.. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991: 64: 841848.
  • 118
    Maccarana M., Casu B., Lindahl U. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J Biol Chem 1993: 268: 2389823905.
  • 119
    Joseph-Silverstein J., Rifkin D B.. Endothelial cell growth factors and the vessel wall. Semin Thromb Hemost 1987: 13: 504513.
  • 120
    Han-Zhang X., Kepley C L., Sakai K., Chelliah J., Irani A M., Schwartz L B.. Quantitation of tryptase, chymase, Fc-RIα, and Fc-RIγ mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction. J Immunol 1995: 154: 54725479.
  • 121
    Levi-Schaffer F., Kupietzky A. Mast cells enhance migration and proliferation of fibroblasts into an in vitro wound. Exp Cell Res 1990: 188: 4249.
  • 122
    Ruoss S J., Hartmann T., Caughey G H.. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 1991: 88: 493499.
  • 123
    Levi-Schaffer F., Rubinchik E. Activated mast cells are fibrogenic for 3T3 fibroblasts. J Invest Dermatol 1995: 104: 9991003.
  • 124
    Schwartz LB. Tryptase, a mediator of human mast cells. J Allergy Clin Immunol 1990: 86: 594598.
  • 125
    Gruber B L., Schwartz L B.. The mast cell as an effector of connective tissue degradation: a study of matrix susceptibility to human mast cells. Biochem Biophys Res Commun 1990: 171: 12721278.
  • 126
    Harvima I T., Horsmanheimo L., Naukkarinen A., Horsmanheimo M. Mast cell proteinases and cytokines in skin inflammation. Arch Dermatol Res 1994: 287: 6167.
  • 127
    Caughey GH, Zerweck EH, Vanderslice P. Structure, chromosomal assignment, and deduced amino acid sequence of a human gene for mast cell chymase. J Biol Chem 1991: 266: 1295612963.
  • 128
    Tharp MD, Carrozza M., Schechter N. et al. Mast cell chymase induces keratinocyte and fibroblast injury. J Invest Dermatol 1992: 98: 594599.
  • 129
    Sanker S., Chandrasekharan U M., Wilk D., Glynias M J., Karnik S S., Husain A. Distinct multisite synergistic interactions determine substrate specificities of human chymase and rat chymase-1 for angiotensin II formation and degradation. J Biol Chem 1997: 272: 29632968.
  • 130
    Steckelings U M., Artuc M., Paul M., Stoll M., Henz B M.. Angiotensin II stimulates proliferation of primary human keratinocytes via a non-AT1, non-AT2 angiotensin receptor. Biochem Biophys Res Commun 1996: 229: 329333.
  • 131
    Di Marco E., Marchisio P C., Bondanza S., Franzi A T., Cancedda R., de Luca M. Growth-regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes. J Biol Chem 1991: 266: 2171821722.
  • 132
    Li A K C., Koroly M J., Schattenkerk M E., Malt R A., Young M. Nerve growth factor: acceleration of the rate of wound healing in mice. Proc Natl Acad Sci 1980: 77: 43794381.
  • 133
    Pincelli C., Sevignani C., Manfredini C. et al. Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J Invest Dermatol 1994: 103: 1318.
  • 134
    Tron V A., Coughlin M D., Jang D E., Stanisz J., Sauder D N.. Expression and modulation of nerve growth factor in murine keratinocytes (PAM 212). J Clin Invest 1990: 85: 10841089.
  • 135
    Yaar M., Grosman K., Eller M., Gilchrest B A.. Evidence for nerve growth factor-mediated paracrine effects in human epidermis. J Cell Biology 1991: 115: 821828.
  • 136
    Hutson J M., Niall M., Evans D., Fowler R. Effect of salivary glands on wound contraction in mice. Nature 1979: 279: 793795.
  • 137
    Marshal J S., Stead R H., McSharry C., Nielsen L., Schwartz J B.. The role of mast cell degranulation products in mast cell hyperplasia. J Immunology 1990: 144: 18661892.
  • 138
    Kawamoto K., Okada T., Kannan Y., Ushio H., Matsumoto M., Matsuda H. Nerve growth factor prevents apoptosis of rat peritoneal cells through the trk proto-oncogene receptor. Blood 1995: 86: 46384644.
  • 139
    Wilkinson D I., Theeuwes M J., Farber E M.. Nerve growth factor increases the mitogenicity of certain growth factors for cultured human keratinocytes: a comparison with epidermal growth factor. Exp Dermatol 1994: 3: 239245.
  • 140
    Di Marco E., Mathor M., Bondanza S. et al. Nerve growth factor binds to normal human keratinocytes through high and low affinity receptors and stimulates their growth by a novel autocrine loop. J Biol Chem 1993: 268: 2283822846.
  • 141
    Fantini F., Johansson O. Expression of growth-associated protein 43 and nerve growth factor receptor in human skin: a comparative immunohistochemical investigation. J Invest Dermatol 1992: 99: 734742.
  • 142
    Bothwell M. Tissue localization of nerve growth factor and nerve growth factor receptors. CTMI 1991: 165: 5570.
  • 143
    DeKosky S T., Styren S D., O'Malley M E. et al. Interleukin-1 receptor antagonist suppresses neurotrophin response in injured rat brain. Ann Neurol 1996: 39: 123127.
  • 144
    Matsuda H., Kannan Y., Ushio H. et al. Nerve growth factor induces development of connective tissue-type mast cells in vitrok from murine bone marrow cells. J Exp Med 1991: 174: 714.
  • 145
    Pearce F L., Thompson H L.. Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. J Physiol 1986: 372: 379393.
  • 146
    Welker P., Grabbe J., Grützkau A., Henz B M.. Effects of NGF and other fibroblast-derived growth factors on immature human mast cells (HMC-1). Immunology, in press.
  • 147
    Fantini F., Gianetti A., Benassi L., Cattaneo V., Magnoni C., Pincelli C. Nerve growth factor receptor and neurochemical markers in human oral mucosa: an immunohistochemical study. Dermatology 1995: 190: 186191.
  • 148
    Lee K F., Li E., Huber L J. et al. Targeted mutation of the gene encoding the low affinity nerve growth factor receptor p 75 leads to deficits in the peripheral sensory nervous system. Cell 1992: 69: 737749.
  • 149
    Ribeiro-Da-Silva A., Kenigsberg R L., Cuello A C.. Sight and electron microscopic distribution of nerve growth factor receptor-like immunoreactivity in the skin of the rat lower lip. Neuroscience 1991: 43: 631646.
  • 150
    Yaar M., Eller M S., DiBenedetto P. et al. The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes. J Clin Invest 1994: 94: 15501562.
  • 151
    Klein R., Jing S., Nanduri V., O'Rourke E., Barbacid M. The trk proto-oncogene encodes a receptor for nerve growth factor receptor. Cell 1991: 65: 189197.
  • 152
    Hempstead B L., Martin-Zanca D., Kaplan D R., Parada L F., Chao M V.. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature 1991: 350: 678683.
  • 153
    Cordon-Cardo C., Tapley P., Jing S. et al. The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3. Cell 1991: 66: 173183.
  • 154
    Grabbe J., Welker P., Dippel E., Czarnetzki B M.. Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch Dermatol Res 1994: 287: 7884.
  • 155
    Weiss R R., Whitaker-Menezes D., Longley J., Bender J., Murphy G F.. Human dermal endothelial cells express membrane-associated mast cell growth factor. J Invest Dermatol 1995: 104: 101106.
  • 156
    Rennick D., Hunte B., Holland G., Thompson-Snipes L. Cofactors are essential for stem cell factor-dependent growth and maturation of mast cell progenitors: comparative effects of interleukin-3 (IL-3), IL-4, IL-10, and fibroblasts. Blood 1995: 85: 5765.
  • 157
    Tsai M., Takeishi T., Thompson H. et al. Induction of mast cell proliferation, maturation, and heparin synthesis by the c-kit ligand, stem cell factor. Proc Natl Acad Sci 1991: 88: 63826386.
  • 158
    Grabarek J., Groopman J E., Lyles Y R. et al. Human kit ligand (stem cell factor) modulates platelet activation in vitro. J Biol Chem 169: 2171821724.
  • 159
    Antoniades H N., Scher C D., Stiles C D.. Purification of human platelet-derived factor. Proc Nat Acad Sci USA 1979: 76: 18091812.
  • 160
    Hammacher A., Hellman U., Johnsson A. et al. A major part of platelet-derived growth factor purified from human platelets is a heterodimer of one A and one B chain. J Biol Chem 1988: 263: 1649316498.
  • 161
    Wennström S., Hawkins P., Cooke F. et al. Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling. Curr Biol 1994: 4: 385393.
  • 162
    Helin C H., Westermark B. Platelet-derived growth factor: Mechanism of action and possible in vivo function. Cell Regul 1990: 1: 555566.
  • 163
    Seppä H., Grotendorst G., Seppä S., Schiefmann E., Martin G R.. Platelet derived growth factor is chemotactic for fibroblasts. J Cell Biol 1990: 92: 584588.
  • 164
    Heldin P., Laurent T C., Heldin C H.. Effect of growth factors on hyaluronon synthesis in cultured human fibroblast. Biochem J 1989: 258: 919922.
  • 165
    Blatti S P., Forster A., Heldin C H., Westermark B. Induction of fibronectin gene transcription and mRNA is a primary response to growth-factor stimulation of AKR-2B cells. Proc Natl Acad Sci USA 1988: 85: 11191123.
  • 166
    Sato N., Beitz J G., Kato J. et al. Platelet-derived growth factor indirectly stimulates angiogenesis in vitro. Am J Pathol 1993: 142: 11191130.
  • 167
    Shimokado K., Raines E W., Madtes D K., Barrett T B., Benditt E P., Ross R. A significant part of macrophagederived growth factor consist of at least two forms of PDGF. Cell 1995: 43: 277286.
  • 168
    Bauer E A., Cooper T W., Huang J S., Altmann J., Deuel T F.. Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor. Proc Natl Acad Sci USA 1985: 82: 41324136.
  • 169
    Brem H., Klagsburn M. The role of fibroblast growth factors and related oncogenes in tumor growth, in: Oncogenes and tumor suppressor genes in human malignancies. Boston : Kluver Academic Publishers, 1993: 211231.
  • 170
    Miyomoto M., Naruo K I., Seko C., Matsumoto S., Kondo T., Kurakawa T. Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property. Mol Cell Biol 1993: 13: 123130.
  • 171
    Burgess W., Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989: 58: 575606.
  • 172
    Sato Y., Rifkin D B.. Autocrine activities of basic fibroblast growth factor. Regulation of endothelial cell movement, plasminoogen activator synthesis, and DNA synthesis. J Cell Biol 1988: 107: 11991205.
  • 173
    Reed J A., Albino A P., McNutt N S.. Human cutaneous mast cells express basic fibroblast growth factor. Lab Invest 1995: 72: 215222.
  • 174
    Inoue Y., King T E., Tinkle S S., Dockstader K., Newman L S.. Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders. Am J Path 1996: 149: 20372054.
  • 175
    Friedl L., Chang Z., Tierney A., Rapraeger A C.. Differential binding of fibroblast growth factor 2 and 7 to basement membrane heparan sulfate. Comparison of normal and abnormal human tissues. Am J Path 1997: 150: 14431455.
  • 176
    Gao G., Goldfarb M. Heparin can activate a receptor tyrosine kinase. EMBO J 1995: 14: 21832190.
  • 177
    Klangsburn M., Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell 1991: 67: 120.
  • 178
    Imaizumi T., Louis J., Bailly C., Cicurel L., Petchot J P., Dubertret L. Effect of human basic fibroblast growth factor on fibroblast proliferation, cell volume, collagen lattice contraction: in comparison with acidic type. J Dermatol Sci 1996: 11: 134141.
  • 179
    Schreier T., Degen E., Baschong W. Fibroblast migration and proliferation during in vitro wound healing. Res Exp Med 1993: 193: 195205.
  • 180
    Buckley A., Woodward S C., Senior S M., Griffin G L., Klagsburn M., Davidson J M.. Differential stimulation of collagenase and chemotactic activity in fibroblasts derived from rat wound repair tissue and human skin by growth factors. J Cell Physiol 1989: 138: 7078.
  • 181
    Mignetti P., Tsuboi R., Robbins W., Rifkin D B.. In vitro angiogenesis on the human amniotic membrane. Requirement for basic fibroblast growth factor induced proteinases. J Cell Biol 1989: 108: 671682.
  • 182
    Longaker M T., Bouhana K S., Harrison M R., Danielpour D., Roberts A B., Banda M J.. Wound healing in the fetus. Possible role for inflammatory macrophages and transforming growth factor-β isoforms. Wound Rep Reg 1994: 2: 104112.
  • 183
    Miyazono K., Ichijo H., Heldin H C.. Transforming growth factor: Latent forms, binding proteins and receptors. Growth Factors 1993: 8: 1122.
  • 184
    Taipale J., Lohi J., Saarinen J., Kovanen P T., Keski-Oja J. Human mast cell chymase and leukocyte elastase release latent transforming growth factor-β1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem 1995: 270: 46894696.
  • 185
    Brown G L., Curtsinger L J., White M. et al. Acceleration of tensile strength of incisions treated with EGF and TGF-beta. Ann Surg 1988: 208: 788794.
  • 186
    Bonewald L F., Wakefield L., Oreffo R O C., Oscebado A., Twardzik D R., Mundy G R.. Latent forms of transforming growth factor β derived from bone cultures: Identification of a naturally occurring 100 kDa complex with similarity to recombinant latent TGF-β. Mol Endocrinol 1991: 5: 741751.
  • 187
    Bornstein P. Thrombospondins-structure and regulation of the expression. FASEB J 1992: 6: 32903299.
  • 188
    Hebda P A.. Stimulatory effects of transforming growth factor-β and epidermal growth factor on epidermal cell outgrowth from porcine skin explant cultures. J Invest Dermatol 1988: 91: 440445.
  • 189
    Ellis I., Grey A M., Schor A M.. Antagonistic effects of TGF-beta 1 and MSF on fibroblast migration and hyaluronic acid synthesis. Possible implications for dermal wound healing. J Cell Sci 1992: 102: 447456.
  • 190
    Wahl S., Hunt D A., Wakefield L M. et al. Transforming growth factor type beta induces monocytes chemotaxis and growth factor production. Proc Natl Acad Sci USA 1987: 84: 57885792.
  • 191
    Adams D H., Hathaway M., Shaw J., Burnett D., Elias E., Strain A J.. Transforming growth factor-beta induces human T lymphocyte migration in vitro. J Immunol 1991: 147: 609612.
  • 192
    Gruber B L., Marchese M J., Kew R R.. Transforming growth factor-β1 mediates mast cell chemotaxis. J Immunol 1994: 152: 58605867.
  • 193
    Philipps G D., Whitead R A., Knighton D R.. Inhibition by methylprednisolone acetate suggests an indirect mechanism for TGF-β induced angiogenesis. Growth Factors 1992: 6: 7784.
  • 194
    Pepper M S., Vassalli J D., Orci L., Montesano R. Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis. Exp Cell Res 1993: 204: 356363.
  • 195
    Hartmann K., Wagelie-Steffen A L., von Stebut E., Metcalfe D D.. Fas (CD95, APO-1) antigen expression and function in murine mast cells. J Immunol 1997: 159: 40064016.